Regencell Bioscience Holdings Ltd
(RGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 3,127,300 | 2,990,100 | 3,038,100 | 2,820,000 | 2,675,900 |
| Cost of Goods | 1,207,500 | 1,158,200 | 1,189,600 | 1,101,600 | 1,050,300 |
| Gross Profit | 1,919,800 | 1,831,900 | 1,848,500 | 1,718,400 | 1,625,600 |
| Operating Expenses | 1,601,000 | 1,525,700 | 1,509,300 | 1,389,000 | 1,410,400 |
| Operating Income | 319,300 | 306,400 | 339,800 | 330,000 | 215,500 |
| Interest Expense | 129,600 | 126,500 | 141,300 | 135,000 | 149,700 |
| Other Income | 63,600 | -1,300 | 66,100 | 36,700 | -13,800 |
| Pre-tax Income | 253,300 | 178,600 | 264,600 | 231,700 | 52,000 |
| Income Tax | 100,100 | 73,400 | 107,000 | 89,500 | 15,400 |
| Net Income Continuous | 153,200 | 105,200 | 157,600 | 142,200 | 36,600 |
| Minority Interests | -200 | -400 | -100 | -100 | -200 |
| Net Income | $153,400 | $105,600 | $157,700 | $142,300 | $36,800 |
| EPS Basic Total Ops | 0.99 | 0.68 | 1.02 | 0.92 | 0.24 |
| EPS Basic Continuous Ops | 0.98 | 0.68 | 1.02 | 0.92 | 0.24 |
| EPS Diluted Total Ops | 0.98 | 0.68 | 1.01 | 0.92 | 0.24 |
| EPS Diluted Continuous Ops | 0.98 | 0.67 | 1.01 | 0.92 | 0.24 |
| EPS Diluted Before Non-Recurring Items | 1.08 | 0.95 | 1.04 | 1.00 | 0.48 |
| EBITDA(a) | $541,100 | $518,400 | $544,300 | $516,200 | $417,200 |